How Recursion is leading a new era of AI-driven drug discovery AI drug discovery is not a new phenomenon – but it is evolving at an almost dizzying pace. Recursion is one of the earliest innovators in ...
New method to tune LLMs is RLMF, reinforcement learning with metacognitive feedback. It is akin to RLAIF and somewhat like ...
Image courtesy by QUE.com How Agentic AI is Redefining Enterprise Operations in 2026 The transition from generative models to ...
Intactis Bio joins the Biocomputing industry, which seeks to deliver lower-energy, cost-efficient computing capacity driven ...
Anthropic's Claude Science integrates 60+ scientific databases into a single AI workbench. What it means for biotech and life ...
TypeScript 7.0 is now stable after Microsoft ported the entire compiler to Go, delivering build-time speedups of 8x to 12x ...
Discover how new AI models are being built using Singapore patients' clinical data to improve healthcare diagnoses and ...
Oppenheimer says SpaceX/Tesla’s Terafab using Intel 18A is critical to SpaceX valuation—AI & space-hardened chips, $120B risk ...
MusicRadar on MSN
"Everything started from a human being": Italian DJ and producer Ciauru wins Reply AI Music Contest
The awards seek to showcase how AI can be used positively in the creative industries ...
At the moment, many of the big AI systems used in drug discovery are closed-source, meaning they are proprietary and carry an ...
Recursive Self-Improvement Now Has a Co-Evolving Evaluator: Cambridge-NVIDIA Paper Raises the Stakes
Visitors tour the Nvidia booth during the Nvidia Product Showcase at Computex 2026 in Taipei on June 3, 2026. AFP via Getty Images/I-Hwa Cheng A preprint published June 24, 2026, by 13 researchers at ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results